GL1X · GenesisL1 explorer

MolNFT v1 · #78200 · protein

AMP-C beta-lactamase (pseudomonas aeruginosa) in complex with a beta- lactamase inhibitor

3S1Y: “AMP-C beta-lactamase (pseudomonas aeruginosa) in complex with a beta- lactamase inhibitor”. X-ray diffraction, 2 ligands (S1Y, CL), 2 pockets (best druggability 0.60). MolNFT v1 #78200 on GenesisL1: 3D structure, binding sites and…

PDB
3S1Y
Type
protein
Length
361 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P24735
Ligands
S1Y, CL
Pockets
2 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein36143% helix, 22% strandP24735

Ligands and binding sites

  • S1Y · [(2S,3R)-1-{[(4S)-1-(2-aminoethyl)azepan-4-yl]carbamoyl}-2-formylpyrrolidin-3-yl]sulfamic acid · ligand · chains A
  • CL · Chloride ion · ion · chains A
  • IPA · Isopropyl alcohol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12530.600.8039S1Y, CL, IPA
2650.310.7516empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 3S1Y · AMP-C BETA-LACTAMASE (PSEUDOMONAS AERUGINOSA) in complex with a beta-lactamase inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P24735 · AlphaFold monomer V2.0 prediction for beta-lactamase (P24735) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.